Bruker (BRKR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
10 Apr, 2026Executive summary
The 2026 Annual Meeting will be held virtually on May 21, 2026, with voting available online, by phone, or by mail.
Proxy materials are distributed electronically to reduce costs, with printed copies available upon request.
The meeting agenda includes director elections, an advisory vote on executive compensation, and ratification of the external auditor.
Forward-looking statements caution about risks from supply chain, macroeconomic, regulatory, and competitive factors.
Voting matters and shareholder proposals
Shareholders will vote to elect three Class II directors for terms expiring in 2029.
An advisory vote will be held on 2025 executive compensation (say-on-pay).
Ratification of PricewaterhouseCoopers LLP as independent auditor for fiscal 2026 is on the agenda.
Shareholders may submit proposals for the 2027 meeting by December 11, 2026.
Board of directors and corporate governance
The board consists of 12 members divided into three classes, with a combined Chairman/CEO and a lead independent director.
All directors except the CEO are independent per Nasdaq rules.
Three standing committees: Audit, Compensation, and Nominating & Governance, each with defined charters and responsibilities.
Board and committees met regularly in 2025, with high attendance rates.
Director nominations consider experience, integrity, independence, and diversity of skills.
Latest events from Bruker
- Virtual annual meeting to vote on directors, executive pay, and auditor ratification.BRKR
Proxy filing10 Apr 2026 - FY26 guidance targets margin and EPS growth despite flat FY25 revenue and margin declines.BRKR
Q4 202512 Feb 2026 - Q2 2024 revenue up 17.4% as acquisitions drive growth, but margins pressured by costs.BRKR
Q2 20242 Feb 2026 - Innovation and acquisitions fuel growth in proteomics, diagnostics, and spatial biology.BRKR
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Strategic acquisitions and innovation drive strong growth and expanded market leadership.BRKR
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Operational excellence and innovation in proteomics and spatial biology drive future growth.BRKR
2024 Wells Fargo Healthcare Conference22 Jan 2026 - Growth driven by innovation, strategic acquisitions, and a robust backlog amid evolving market dynamics.BRKR
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Q3 revenue up 16.4% but margins and EPS declined; FY2024 guidance lowered.BRKR
Q3 202416 Jan 2026 - 2024 growth outpaces peers; 2025 targets mid-teens EPS growth and margin expansion.BRKR
Stifel 2024 Healthcare Conference13 Jan 2026